| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.81B | 57.37B | 55.74B | 52.99B | 54.77B | 46.36B |
| Gross Profit | 9.72B | 8.66B | 9.84B | 8.39B | 10.15B | 9.41B |
| EBITDA | 6.60B | 6.12B | 6.72B | 5.53B | 7.63B | 7.11B |
| Net Income | 2.20B | -877.00M | 2.42B | 1.87B | 2.99B | 2.85B |
Balance Sheet | ||||||
| Total Assets | 88.20B | 88.56B | 88.34B | 82.71B | 75.72B | 72.13B |
| Cash, Cash Equivalents and Short-Term Investments | 12.43B | 11.27B | 14.09B | 14.31B | 11.66B | 13.06B |
| Total Debt | 11.49B | 12.38B | 12.53B | 9.53B | 6.86B | 5.00B |
| Total Liabilities | 28.73B | 27.07B | 28.94B | 24.94B | 22.06B | 20.86B |
| Stockholders Equity | 58.93B | 60.97B | 58.84B | 57.29B | 53.22B | 50.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.17B | -2.28B | 1.36B | -2.11B | 2.37B |
| Operating Cash Flow | 0.00 | 4.54B | 5.06B | 4.98B | 581.00M | 4.84B |
| Investing Cash Flow | 0.00 | -6.21B | -7.08B | -3.95B | -2.98B | -2.81B |
| Financing Cash Flow | 0.00 | -1.20B | 1.68B | 1.45B | 825.00M | -2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥173.02B | 12.35 | ― | 3.50% | 4.44% | 4.49% | |
75 Outperform | ¥52.46B | 25.62 | 9.07% | 4.46% | 3.09% | 22.56% | |
70 Outperform | ¥84.99B | 10.06 | ― | 3.74% | 0.53% | 30.98% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥42.11B | -44.17 | ― | 3.24% | 2.94% | -136.46% | |
56 Neutral | ¥331.00B | 32.98 | 6.95% | 3.06% | -6.88% | ― | |
46 Neutral | ¥141.77B | -14.77 | 4.24% | 3.76% | -0.20% | -276.01% |